Company research
Sotera Health Co
CIK 1822479Updated Sep 24, 2026
SecuritySHC · NASDAQ · equity
Name history
Sotera Health Topco, Inc. · through Oct 9, 2020
SHC price & chart
Loading TradingView…
NASDAQ:SHC on TradingView ↗About the company
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®. Updates on recent developments in matters relevant to investors can be found on the Investor Relations section of the Sotera Health website at Investor Relations | Sotera Health. For developments related to EO, updates can be found at Ethylene Oxide | Sotera Health.
In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 3,263,190,000Source | 3,071,648,000Source | 3,130,420,000Source | 3,117,705,000Source |
| GoodwillUSD | 1,103,232,000Source | 1,081,073,000Source | 1,111,190,000Source | 1,101,768,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 288,227,000Source | 317,653,000Source | 416,318,000Source | 491,265,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 344,621,000Source | 277,242,000Source | 296,407,000Source | 395,214,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 139,329,000Source | 140,327,000Source | 147,696,000Source | 118,482,000Source |
| Inventory, NetUSD | 54,375,000Source | 49,158,000Source | 48,316,000Source | 37,145,000Source |
| Assets, CurrentUSD | 613,410,000Source | 526,037,000Source | 557,244,000Source | 645,010,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 65,250,000Source | 51,031,000Source | 53,846,000Source | 80,995,000Source |
| Operating Lease, Right-of-Use AssetUSD | 33,393,000Source | 27,551,000Source | 24,037,000Source | 26,481,000Source |
| Other Assets, NoncurrentUSD | 36,694,000Source | 37,053,000Source | 41,242,000Source | 38,983,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,657,155,000Source | 2,666,737,000Source | 2,686,686,000Source | 2,767,467,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 2,860,000Source | 2,860,000Source | 2,860,000Source | 2,860,000Source |
| Additional Paid in CapitalUSD | 1,262,119,000Source | 1,243,778,000Source | 1,215,178,000Source | 1,189,622,000Source |
| Retained Earnings (Accumulated Deficit)USD | -532,093,000Source | -610,042,000Source | -654,440,000Source | -705,816,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -109,838,000Source | -208,251,000Source | -92,682,000Source | -106,653,000Source |
| Stockholders' Equity Attributable to ParentUSD | 606,035,000Source | 404,911,000Source | 443,734,000Source | 350,238,000Source |
| Liabilities and EquityUSD | 3,263,190,000Source | 3,071,648,000Source | 3,130,420,000Source | 3,117,705,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 249,584,000Source | 191,002,000Source | 230,654,000Source | 791,567,000Source |
| Operating Lease, Liability, CurrentUSD | 5,755,000Source | 5,056,000Source | 5,934,000Source | 7,554,000Source |
| Accounts Payable, CurrentUSD | 77,963,000Source | 55,098,000Source | 71,039,000Source | 74,139,000Source |
| Operating Lease, Liability, NoncurrentUSD | 29,901,000Source | 24,465,000Source | 20,087,000Source | 21,577,000Source |
| Deferred Income Tax Liabilities, NetUSD | 71,075,000Source | 69,500,000Source | 64,454,000Source | 68,024,000Source |
| Other Liabilities, NoncurrentUSD | 7,360,000Source | 4,418,000Source | 8,879,000Source | 12,831,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | — | — | 0Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 124,736,000Source | 90,463,000Source | 122,471,000Source | 490,130,000Source |
| Deferred Tax Liabilities, NetUSD | 67,222,000Source | 66,635,000Source | 59,461,000Source | 63,923,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 13,973,000Source | 14,803,000Source | 4,797,000Source | 197,119,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 2,126,724,000Source | 2,208,100,000Source | 2,223,674,000Source | 1,747,115,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 77,949,000Source | 44,398,000Source | 51,376,000Source | -233,570,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 94,900,000Source | 84,300,000Source | 76,600,000Source | 64,300,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 30,878,000Source | 36,777,000Source | 32,238,000Source | 21,211,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -7,151,000Source | -2,216,000Source | 21,724,000Source | 12,555,000Source |
| Increase (Decrease) in InventoriesUSD | 2,377,000Source | 4,753,000Source | 9,972,000Source | -14,441,000Source |
| Increase (Decrease) in Accounts PayableUSD | 5,185,000Source | -6,644,000Source | -5,333,000Source | 1,107,000Source |
| Deferred Income Tax Expense (Benefit)USD | 22,000Source | 9,433,000Source | 3,449,000Source | -73,960,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 287,195,000Source | 224,164,000Source | -147,732,000Source | 277,961,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | 0Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -135,144,000Source | -178,996,000Source | -214,906,000Source | -181,896,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -2,874,000Source | -74,000Source | -69,000Source | -32,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 138,018,000Source | 179,070,000Source | 214,975,000Source | 182,378,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 6,568,000Source | 4,428,000Source | 4,089,000Source | 393,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -100,534,000Source | -50,564,000Source | 265,959,000Source | 197,761,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -3,488,000Source | -2,306,000Source | -1,807,000Source | -1,815,000Source |
| Repayments of Long-term DebtUSD | 86,104,000Source | 2,264,373,000Source | 2,500,000Source | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 67,591,000Source | -22,789,000Source | -94,640,000Source | 289,370,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 346,456,000Source | 278,865,000Source | 301,654,000Source | 396,294,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 164,015,000Source | 179,924,000Source | 173,842,000Source | 75,849,000Source |
| Income Taxes Paid, NetUSD | 60,873,000Source | 65,829,000Source | 50,210,000Source | 75,496,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 16,074,000Source | -17,393,000Source | 2,039,000Source | -4,456,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 30,400,000Source | 19,100,000Source |
| Amortization of Debt Issuance CostsUSD | 5,434,000Source | 7,238,000Source | 9,051,000Source | 5,681,000Source |
| Amortization of Intangible AssetsUSD | 41,798,000Source | 79,377,000Source | 81,348,000Source | 81,554,000Source |
| Asset Retirement Obligation, Accretion ExpenseUSD | 2,321,000Source | 2,638,000Source | 2,413,000Source | 2,194,000Source |
| DepreciationUSD | 94,908,000Source | 84,260,000Source | 76,577,000Source | 64,000,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | 0Source | 0Source | 9,613,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -947,000Source | -199,000Source | -159,000Source | -145,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | -9,517,000Source | 18,337,000Source | -6,057,000Source | 3,984,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | -408,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source |
| GoodwillUSD | 1,103,232,000Source | 1,081,073,000Source | 1,111,190,000Source | 1,101,768,000Source |
| Income Tax Expense (Benefit)USD | 69,557,000Source | 69,476,000Source | 54,651,000Source | -9,541,000Source |
| Net Income (Loss) Attributable to ParentUSD | 77,949,000Source | 44,398,000Source | 51,376,000Source | -233,570,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 77,945,000Source | 44,339,000Source | 51,089,000Source | -233,570,000Source |
| Operating ExpensesUSD | — | 304,669,000Source | 300,466,000Source | 308,654,000Source |
| Other Nonoperating Income (Expense)USD | 8,546,000Source | 5,306,000Source | 7,372,000Source | 6,441,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 0Source |
| Proceeds from Issuance of Long-term DebtUSD | 0Source | 2,259,350,000Source | 500,000,000Source | 200,000,000Source |
| Unrealized Gain (Loss) on DerivativesUSD | 863,000Source | -2,213,000Source | 1,637,000Source | -2,977,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,163,617,000Source | 1,100,441,000Source | 1,049,288,000Source | 1,003,687,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 252,762,000Source | 242,630,000Source | 236,667,000Source | 245,714,000Source |
| Operating Income (Loss)USD | — | 297,626,000Source | 276,692,000Source | 248,350,000Source |
| Other Nonoperating Income (Expense)USD | 8,546,000Source | 5,306,000Source | 7,372,000Source | 6,441,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 147,506,000Source | 113,874,000Source | 106,027,000Source | -243,111,000Source |
| Income Tax Expense (Benefit)USD | 69,557,000Source | 69,476,000Source | 54,651,000Source | -9,541,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 77,949,000Source | 44,398,000Source | 51,376,000Source | -233,570,000Source |
| Earnings Per Share, BasicUSD per share | 0.27Source | 0.16Source | 0.18Source | -0.83Source |
| Earnings Per Share, DilutedUSD per share | 0.27Source | 0.16Source | 0.18Source | -0.83Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 283,956,000Source | 282,784,000Source | 281,008,000Source | 280,096,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 286,421,000Source | 284,906,000Source | 283,222,000Source | 280,096,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 41,798,000Source | 79,377,000Source | 81,348,000Source | 81,554,000Source |
| Current Income Tax Expense (Benefit)USD | 69,535,000Source | 60,043,000Source | 51,202,000Source | 64,419,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -947,000Source | -199,000Source | -159,000Source | -145,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | -408,000,000Source |
| Gross ProfitUSD | 645,534,000Source | 602,295,000Source | 577,158,000Source | 557,004,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -69,357,000Source | -116,049,000Source | -100,635,000Source | -418,308,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -155,722,000Source | -164,691,000Source | -142,878,000Source | -80,144,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 77,945,000Source | 44,339,000Source | 51,089,000Source | -233,570,000Source |
| Operating ExpensesUSD | — | 304,669,000Source | 300,466,000Source | 308,654,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | 4,000Source | 59,000Source | 287,000Source | 0Source |
Filing attachments
august62026-ex991.htm · 8-K · 2026-08-06
EX-99.1 2 august62026-ex991.htm EX-99.1 Document Exhibit 99.1 Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook • Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis(1) compared to Q2 2025 • Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025 • Q2 2026 Adjusted EBITDA(1) increased 10.0%, or 8.7% on a constant currency basis • Q2 20…
Read attachment ↗may52026-ex991.htm · 8-K · 2026-05-05
EX-99.1 2 may52026-ex991.htm EX-99.1 Document Exhibit 99.1 Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook • Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025 • Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 • Q1 2026 Adjusted EBITDA(1) increased 10.5%, or 6.9% on a constant currency basis • Q1 2026 Adjusted EPS(1)…
Read attachment ↗